Reviewing clinical cases over the past five years reveals a clear trend in treatment selection: most patients received R-CHOP chemotherapy (with or without radiotherapy), followed by surgical intervention.
← all excerpts
Primary extranodal marginal zone non-hodgkin lymphoma of the prostate: a case report.
1
—
—